Suchergebnisse - "Barlesi, F"

PubPharm (14)

1

Harnessing tumor immunity with cytotoxics : T cells monitoring in mice bearing lung tumors treated with anti-VEGF and pemetrexed-cisplatin doublet

enthalten in: British journal of cancer | 2023

von Sicard, G. | Protzenko, D. | Giacometti, S. | +3

2

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2022

von Trédaniel, J. | Barlési, F. | Le Péchoux, C. | +19

3

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients

enthalten in: British journal of cancer | 2017

von Faivre, C. | El Cheikh, R. | Barbolosi, D. | +1

4

Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation : a randomised phase II trial GFPC - IFCT 02-01

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Fournel, P. | Vergnenégre, A. | Robinet, G. | +90

5

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients : results of an open-label, randomized, controlled phase II study (CERTO)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Vansteenkiste, J. | Barlesi, F. | Waller, C. | +16

6

Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer : results from the IFCT-0802 trial†

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Pujol, J. | Lavole, A. | Quoix, E. | +50

CommentIn: Ann Oncol. 2015 Sep;26(9):2003. - PMID 26113649

7

Systemic treatment of brain metastases from lung cancer

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2015

von Barlesi, F. | Spano, J. | Cortot, A. | +3

8

First-line crizotinib versus chemotherapy in ALK-positive lung cancer

enthalten in: The New England journal of medicine | 2014

von Solomon, B. | Mok, T. | Kim, D. | +113

CommentIn: N Engl J Med. 2014 Dec 4;371(23):2227-8. - PMID 25470699

9

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Novello, S. | Besse, B. | Felip, E. | +12

10

Maintenance bevacizumab-pemetrexed after first-line cisplatin-pemetrexed-bevacizumab for advanced nonsquamous nonsmall-cell lung cancer : updated survival analysis of the AVAPERL (MO22089) randomized phase III trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Barlesi, F. | Scherpereel, A. | Gorbunova, V. | +14